Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis
Background: Several recent studies have reported the reliable prognostic effect of hematological biomarkers in various tumors. Yet, the prognostic value of these hematological markers in soft tissue sarcoma (STS) remains inconclusive. Thus, the aim of this meta-analysis was to check the effect of he...
Main Authors: | Long-Qing Li, Zhen-Hua Bai, Liang-Hao Zhang, Yan Zhang, Xin-Chang Lu, Yi Zhang, Yong-Kui Liu, Jia Wen, Jia-Zhen Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00030/full |
Similar Items
-
Integrated Analysis of TME and Hypoxia Identifies a Classifier to Predict Prognosis and Therapeutic Biomarkers in Soft Tissue Sarcomas
by: Ruiling Xu, et al.
Published: (2022-11-01) -
Integrative Clustering Reveals a Novel Subtype of Soft Tissue Sarcoma With Poor Prognosis
by: Zhenhua Zhu, et al.
Published: (2020-02-01) -
Stemness Subtypes and Scoring System Predict Prognosis and Efficacy of Immunotherapy in Soft Tissue Sarcoma
by: Hui-Yun Gu, et al.
Published: (2022-04-01) -
Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study
by: Thomas Brodowicz, et al.
Published: (2020-12-01) -
Results of resection of forearm soft tissue sarcoma
by: Eiji Nakata, et al.
Published: (2023-08-01)